loading page

Calculated globulin is clinically useful as a screening test for antibody deficiency in Turkish adult patients
  • +11
  • Aslı Akkor,
  • Osman Ozan Yeğit,
  • Pelin Karadağ,
  • Deniz Eyice Karabacak,
  • Nida Oztop,
  • Şengül Beyaz,
  • Can Tuzer,
  • Ali Can,
  • semra demir,
  • Derya Ünal,
  • Halim İşsever,
  • Sema Genç,
  • Beyhan Ömer,
  • Stephen Jolles
Aslı Akkor
Istanbul Universitesi Istanbul Tip Fakultesi

Corresponding Author:[email protected]

Author Profile
Osman Ozan Yeğit
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Pelin Karadağ
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Deniz Eyice Karabacak
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Nida Oztop
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Şengül Beyaz
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Can Tuzer
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Ali Can
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
semra demir
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Derya Ünal
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Halim İşsever
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Sema Genç
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Beyhan Ömer
Istanbul Universitesi Istanbul Tip Fakultesi
Author Profile
Stephen Jolles
University Hospital of Wales
Author Profile

Abstract

Backgrounds: Heterogeneous clinical features of antibody deficiency (AD) may cause diagnostic delays. Calculated globulin (CG) (total protein minus albumin) has been proposed as a screening test to prevent morbidity due to diagnostic delays in AD. Our aim is to validate CG as a screening test in AD in Turkish adult patients by comparing its role with gamma globulin analysis in protein electrophoresis. Methods: Fifty serum samples were randomly collected for each level of CG from 1.5 to 2.5 mg/dl and tested for serum IgG, IgA, IgM levels and protein electrophoresis. Cut-off values predicting low IgG levels were calculated for electrophoretically determined gamma globulin and CG. Additionally, the data of 47 patients followed up in our clinic with a diagnosis of primary antibody deficiency (PAD) were retrospectively analyzed. Results: A total of 550 adult patients were included in the study. The CG value predicting patients with IgG <600 mg/dl as a screening test was determined as <2.0 with 83.8% sensitivity and 74.9% specificity. The gamma globulin value which predicted patients with the same IgG value of 89.0% sensitivity and 89.4% specificity was determined as <0.7. In the retrospective analysis, 37 of 47 patients (78.7%) with PAD had a CG value of <2.0 at the time of the diagnosis and all 13 patients (%100) whose gamma globulin values were measured at the time of the diagnosis had a gamma globulin value of <0.7. Conclusion: The determined CG cut-off value of <2.0 can be used as a screening test in Turkish adult patients.